SA
HLTH

Shilanski & Associates’s Cue Health Inc. Common Stock HLTH Stock Holding History

Shilanski & Associates’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$30K – 224
2022
Q3 		$30K Buy
+10,000
New +$35.4K 0.01% 138

Other funds holding HLTH

KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shilanski & Associates's HLTH Position: Q4 2022 in Review

Shilanski & Associates sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2022, closing a stake of 10,000 shares — an estimated $30K sold.

Shilanski & Associates first reported a position in HLTH in Q3 2022 and held it in 1 quarter. The position peaked at $30K in Q3 2022. 96 funds tracked by Wall St. Rank hold HLTH as of Q4 2022.

  • Shilanski & Associates reported no remaining Cue Health Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Shilanski & Associates sold 10,000 Cue Health Inc. Common Stock shares in Q4 2022, an estimated $30K.
  • Shilanski & Associates first reported a position in Cue Health Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Shilanski & Associates's Cue Health Inc. Common Stock position peaked at $30K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2022.

Based on Shilanski & Associates's 13F filing for Q4 2022, filed 31 Jan 2023.